Affordable Access

The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission.

Authors
  • Napolitano, A
  • Cesura, A M
  • Da Prada, M
Type
Published Article
Journal
Journal of neural transmission. Supplementum
Publication Date
Jan 01, 1995
Volume
45
Pages
35–45
Identifiers
PMID: 8748607
Source
Medline
License
Unknown

Abstract

The action of dopamine (DA) released in the synaptic cleft is mainly terminated by its reuptake and catabolism by the enzymes monoamine oxidase (MAO) and catechol O-methyltransferase (COMT). Preclinical data show that the reduction of the catabolism of DA elicited by MAO and COMT inhibitors leads to an enhancement of DA neurotransmission. Moreover, there is evidence suggesting that MAO-B inhibition might protect DA neurons from oxidative stress. Nevertheless, due to differences in enzyme localization and activity between man and rodents, results obtained in experimental animals might not reflect the actual situation in humans. Today the availability of potent and selective MAO and COMT inhibitors makes it feasible for the clinician to test whether the blockade of catabolic enzymes would result in a symptomatic improvement in Parkinsonian patients, and whether MAO-B inhibition might additionally exert a neuroprotective effect.

Report this publication

Statistics

Seen <100 times